Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma

NCT02840539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Bortezomib, Cytarabine, Dexamethasone, Pegteograstim

Sponsor

Seoul National University Hospital

Collaborators

[object Object]